Antwerp Biotech Campus Permit Annulled by Court

The Flemish government has been overruled in a significant legal setback for Belgium’s biotechnology sector. The Raad voor Vergunningsbetwistingen (Council for Permit Disputes) has annulled the environmental permit for Bioscape, an ambitious biotech campus planned on the University of Antwerp’s Drie Eiken site in Edegem/Wilrijk, according to Het Laatste Nieuws.

The project, developed by the company Biovest, was set to create a high-end biotechnology and pharmaceutical research center with up to 500 new jobs. The annulment follows a legal challenge by neighborhood residents who raised concerns about mobility impacts, loss of green space, and insufficient parking.

The Bioscape Project

The Bioscape concept is modeled on a successful biotech hub in Ghent’s Zwijnaarde district, where collaboration between Ghent University and the Flemish Institute for Biotechnology (VIB) produced success stories like Argenx, which grew into an international billion-dollar company. The Antwerp project, developed by Biovest on land leased from the University of Antwerp, aims to create a similar ecosystem for life sciences innovation.

Located adjacent to the University Hospital Antwerp (UZA) and near Vaccinopolis, the project would encompass nearly 28,000 square meters across three new research buildings, laboratories, and meeting spaces. At full capacity, it could support more than 500 high-skilled jobs in biotechnology and pharmaceuticals.

The Flemish government had originally granted the permit in September 2025, after Environment Minister Jo Brouns (CD&V) approved the project following adjustments for mobility concerns. As VRT NWS reported at the time, the adjustments included extra turning lanes on the Drie Eikenstraat and a passage for cyclists. Brouns emphasized the project’s importance, stating that it gives innovation and research in Flanders a solid push while incorporating green-blue elements and a passage for cyclists and walkers.

Neighborhood Opposition

Despite the government’s enthusiasm, neighborhood residents were not convinced. In October 2025, resident Elias Espinos articulated the community’s concerns about the project’s impact on the area’s ecological value. “A whole row of large, mature and healthy trees will be cut down,” he told Het Laatste Nieuws. “The site is part of a valley area with ecological value. Today the site lies fallow, overgrown, and fulfills an ecological and landscape function with the return of birds of prey, meadow birds and insects. It is open space and that open space deserves protection.”

The residents argued that the project would pave over a zone that, according to the regional land use plan, should maintain a park character. They filed an appeal with the Council for Permit Disputes, supported by a crowdfunding campaign and the local opposition party Lijst voor Edegem.

The Court’s Decision

The Council for Permit Disputes sided with the residents, finding that the Flemish government had insufficiently investigated the project’s mobility impact. According to the court, the mobility effects report (MOBER) identified clear bottlenecks around car traffic flow and cyclist safety that were not adequately addressed.

The court was also critical of the proposed mitigation measures. “The Flemish government refers in its decision to road works that should remedy this, but those works have not yet been applied for or permitted, let alone carried out,” the Council stated. “There also appears to be a shortage of parking spaces during events on campus, for which no elaborated solution exists.”

A Broader Debate

The annulment has reignited a broader debate in Flanders about the balance between economic development, environmental protection, and procedural rights. The Flemish Employers’ Network (Voka) has been particularly vocal, arguing that the system has become unbalanced.

“Today, one appeal from one resident is enough to throw a socially relevant project, good for about five hundred jobs, into uncertainty for months,” said Pieter Leuridan, Voka spokesperson, as reported by Made in. In a statement on its website, Voka argued that “when individual procedural rights weigh so heavily that they can block strategic investments, even after a permit was granted following thorough review, then we must dare to acknowledge that the system has become unbalanced.”

Voka also warned that Flanders risks missing a unique opportunity to build a full-fledged ecosystem around biotechnology and vaccine research that could compete with the world’s best, as outlined in its analysis.

However, the residents’ lawyer, Koenraad Van De Sijpe, pushed back against the criticism. “We know that Voka is the mouthpiece of entrepreneurial Flanders,” he said. “That doesn’t change the fact that one must follow the rules. And here they are taking liberties with the provision from the regional plan that states that the natural and landscape qualities of the site must be taken into account when developing the area.”

Local officials remain firmly behind the project. Edegem Mayor Koen Metsu (N-VA) called Bioscape “a unique opportunity for Edegem to play a pioneering role in the Flemish biotech sector,” while Environment Schepen Albert Follens (N-VA) noted that “in Flanders we have no raw materials, only brains.”

The University of Antwerp, which owns the land and leased it to Biovest, also supports the project. “The interaction between companies, hospitals, the university and other partners means added value for the region,” said spokesperson Peter De Meyer.

What’s Next

The annulment sends the dossier back to the Flemish government, which now has three months to re-examine the application and provide more conclusive solutions to the mobility concerns identified by the court. Until then, the ambitious biotech project remains on hold.

The case highlights a growing tension in Belgium between the desire to attract strategic investments in high-tech sectors and the legal protections available to citizens concerned about the environmental and social impacts of development. As the Flemish government works to address the court’s concerns, the outcome will be closely watched by both the biotech industry and community groups across the country.

For now, the question remains whether the Flemish government can develop solutions that satisfy both the court’s requirements and the neighborhood’s concerns - and whether the Bioscape project can ultimately move forward in a way that balances innovation with environmental stewardship.